PMC:7696151 / 9949-10149 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"299","span":{"begin":109,"end":117},"obj":"Species"},{"id":"300","span":{"begin":181,"end":189},"obj":"Species"},{"id":"309","span":{"begin":20,"end":25},"obj":"Species"},{"id":"312","span":{"begin":38,"end":41},"obj":"Chemical"},{"id":"313","span":{"begin":145,"end":148},"obj":"Chemical"},{"id":"336","span":{"begin":96,"end":108},"obj":"Disease"}],"attributes":[{"id":"A299","pred":"tao:has_database_id","subj":"299","obj":"Tax:9606"},{"id":"A300","pred":"tao:has_database_id","subj":"300","obj":"Tax:9606"},{"id":"A309","pred":"tao:has_database_id","subj":"309","obj":"Tax:11676"},{"id":"A312","pred":"tao:has_database_id","subj":"312","obj":"MESH:D006886"},{"id":"A313","pred":"tao:has_database_id","subj":"313","obj":"MESH:D006886"},{"id":"A336","pred":"tao:has_database_id","subj":"336","obj":"MESH:D015658"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"rial about the anti-HIV-1 activity of HCQ was published in 1995. In this study, 40 asymptomatic HIV-infected patients received either 800 mg/day HCQ or placebo for eight weeks. All patients treated wi"}

{"project":"LitCovid-sentences","denotations":[{"id":"T84","span":{"begin":65,"end":176},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"rial about the anti-HIV-1 activity of HCQ was published in 1995. In this study, 40 asymptomatic HIV-infected patients received either 800 mg/day HCQ or placebo for eight weeks. All patients treated wi"}